S&P 500 — US Large Cap Index
FTSE 100 — UK Blue Chips
Euro Stoxx 50 — Eurozone Leaders
DAX 40 — German Equities
CAC 40 — French Market Index
Nikkei 225 — Japan Benchmark
Hang Seng — Hong Kong Index
Shanghai Composite — China Mainland
ASX 200 — Australian Market
TSX Composite — Canada Index
Nifty 50 — India Large Cap
STI Index — Singapore Market
KOSPI — South Korea Index
Bovespa — Brazil Equities
JSE Top 40 — South Africa Index
IPC Index — Mexico Market
The Hang Seng Index rose 1.1%, or 282 points, to 25,791 on Wednesday, following gains on Wall Street overnight as technology stocks rebounded, while easing crude oil prices and lower US Treasury yields offered some support to Asian equities, although uncertainty surrounding US-Iran developments kept investors cautious. The rise was led by healthcare stocks, with Innovent Biologics climbing 10.5%, while broader sentiment was also supported by gains in tech shares. Meanwhile, Alibaba was also in focus after Chairman Joe Tsai bought an additional 720,000 shares worth about HK$82 million, following recent purchases by other senior executives. The buying helped ease concerns over the company’s HK$80 billion share placement to fund its AI expansion, which is expected to close on Wednesday. Notable movers included Tencent (1.0%), Wuxi Biologics (2.1%), Xiaomi (2.0%), Meituan (2.3%), and Akeso (7.4%).
